UTI

A Clinical Research Study to Eliminate Frequent UTIs

The ELIMINATE study aims to see if a new innovative treatment is safe and effective in treating drug-resistant UTIs.

Get Your Patient Form
Clinical Research Partners (7110 Forest Avenue, Suite 201, Richmond, VA 23226)
804-250-9859
Recruitment@ClinicalResearchRVA.com
Get Your Patient Form
Summary

25%-50% of women who experience a UTI will experience multiple recurrent episodes. The ELIMINATE study aims to see if a new innovative treatment is safe and effective in treating drug-resistant UTIs

Age

Women between the ages of 18 to 70

Qualifications

  • Have had at least one UTI in the past 12 months
  • Have a current UTI
  • Other selection criteria apply

Compensation

  • You may be compensated for time and travel.

Meet Our Team

Our experienced team will guide you through the process

Meet the Team

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD